NEW YORK, March 20, 2018 /PRNewswire/ -- Kerrisdale Capital, a private investment manager, has published a negative report
The full report can be found at http://kerr.co/pti.
Kerrisdale has a short position in Proteostasis Therapeutics, Inc., and stands to benefit if its share price falls.
Conference Call ScheduleKerrisdale will host a conference call on Tuesday, March 20 at 10:30am ET to discuss the Proteostasis report.
To participate in the conference call, dial (866) 834-3313 (United States) or (409) 981-0700 (international) and reference the Kerrisdale Capital call.
About Kerrisdale CapitalKerrisdale Capital Management, LLC, is a fundamentally-oriented investment manager that focuses on long-term value investments and event-driven special situations.
ContactAgnes CaoKerrisdale Capital firstname.lastname@example.org 212-257-4385
Kerrisdale Capital Management, LLC is a member of the Financial Industry Regulatory Authority, CRD number 160804.
View original content:http://www.prnewswire.com/news-releases/sahm-adrangis-kerrisdale-capital-issues-negative-report-on-proteostasis-therapeutics-inc-and-announces-conference-call-schedule-300616553.html
SOURCE Kerrisdale Capital Management, LLC
Subscribe to our Free Newsletters!